Peak Width of Skeletonized Mean Diffusivity: A Neuroimaging Marker for White Matter Injury.

A leading cause of white matter (WM) injury in older individuals is cerebral small vessel disease (SVD). Cerebral SVD is the most prevalent vascular contributor to cognitive impairment and dementia. Therapeutic progress for cerebral SVD and other WM disorders depends on the development and validation of neuroimaging markers suitable as outcome measures in future interventional trials. Diffusion-tensor imaging (DTI) is one of the best-suited MRI techniques for assessing the extent of WM damage in the brain. But the optimal method to analyze individual DTI data remains hindered by labor-intensive and time-consuming processes. Peak width of skeletonized mean diffusivity (PSMD), a recently developed fast, fully automated DTI marker, was designed to quantify the WM damage secondary to cerebral SVD and reflect related cognitive impairment. Despite its promising results, knowledge about PSMD is still limited in the radiologic community. This focused review provides an overview of the technical details of PSMD while synthesizing the available data on its clinical and neuroimaging associations. From a critical expert viewpoint, the authors discuss the limitations of PSMD and its current validation status as a neuroimaging marker for vascular cognitive impairment. Finally, they point out the gaps to be addressed to further advance the field.

[1]  Lauren E. Oberlin,et al.  Late-life depression accentuates cognitive weaknesses in older adults with small vessel disease , 2021, Neuropsychopharmacology.

[2]  C. Gerloff,et al.  White matter integrity and structural brain network topology in cerebral small vessel disease: The Hamburg city health study , 2020, Human brain mapping.

[3]  Nick A. Weaver,et al.  Small vessel disease more than Alzheimer's disease determines diffusion MRI alterations in memory clinic patients , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[4]  P. Sachdev,et al.  Plasma lipidomic biomarker analysis reveals distinct lipid changes in vascular dementia , 2020, Computational and structural biotechnology journal.

[5]  C. Gerloff,et al.  Network Localisation of White Matter Damage in Cerebral Small Vessel Disease , 2020, Scientific Reports.

[6]  Eric E. Smith,et al.  Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy , 2020, NeuroImage: Clinical.

[7]  J. O'Brien,et al.  Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage , 2020, Frontiers in Neuroscience.

[8]  I. Deary,et al.  Age-Related Changes of Peak Width Skeletonized Mean Diffusivity (PSMD) Across the Adult Lifespan: A Multi-Cohort Study , 2020, bioRxiv.

[9]  W. Chu,et al.  Peak width of skeletonized mean diffusivity and its association with age-related cognitive alterations and vascular risk factors , 2019, Alzheimer's & dementia.

[10]  Stuart J. Ritchie,et al.  Brain Peak Width of Skeletonized Mean Diffusivity (PSMD) and Cognitive Function in Later Life , 2019, Front. Psychiatry.

[11]  K. Kapur,et al.  Reproducibility of Structural and Diffusion Tensor Imaging in the TACERN Multi-Center Study , 2019, Front. Integr. Neurosci..

[12]  R. Steele,et al.  Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis , 2019, Statistical methods in medical research.

[13]  Richard Frayne,et al.  Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration , 2019, Alzheimer's & dementia.

[14]  L. Yao,et al.  A Neuroimaging Marker Based on Diffusion Tensor Imaging and Cognitive Impairment Due to Cerebral White Matter Lesions , 2019, Front. Neurol..

[15]  Rajikha Raja,et al.  Review of diffusion MRI studies in chronic white matter diseases , 2019, Neuroscience Letters.

[16]  Sridar Narayanan,et al.  Scan-rescan repeatability and cross-scanner comparability of DTI metrics in healthy subjects in the SPRINT-MS multicenter trial. , 2018, Magnetic resonance imaging.

[17]  Martin Rossor,et al.  White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease , 2018, Brain : a journal of neurology.

[18]  Mark E Bastin,et al.  Ageing and brain white matter structure in 3,513 UK Biobank participants , 2016, Nature Communications.

[19]  R. Fields,et al.  White matter and cognition: making the connection. , 2016, Journal of neurophysiology.

[20]  F. de Leeuw,et al.  A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms , 2016, Annals of neurology.

[21]  S. Greenberg,et al.  Ischemic brain injury in cerebral amyloid angiopathy , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  D. Auer,et al.  Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain , 2015, NMR in biomedicine.

[23]  Benjamin S. Aribisala,et al.  White matter hyperintensities and normal-appearing white matter integrity in the aging brain , 2015, Neurobiology of Aging.

[24]  Á. Gil,et al.  Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review , 2013, BMC Public Health.

[25]  C. Lebel,et al.  Diffusion tensor imaging of white matter tract evolution over the lifespan , 2012, NeuroImage.

[26]  Elizabeth Fisher,et al.  Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlations , 2011, Annals of neurology.